Inside USP: USP Metals Testing: A Workshop Report - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Inside USP: USP Metals Testing: A Workshop Report
Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.


Pharmaceutical Technology
Volume 32, Issue 11, pp. 152-153

References

1. USP 31–NF 26 General Chapter <231>, "Heavy Metals," pp. 133–134.

2. T. Wang et al., "An Atomic Spectroscopic Method as an Alternative to Both USP Heavy Metals <231> and USP Residue on Ignition <281>," Pharm Forum. 29 (4), 1328–1336 (2003).

3. USP Ad Hoc Advisory Panel on Inorganic Impurities and Heavy Metals, "General Chapter on Inorganic Impurities: Heavy Metals," Pharm. Forum. 34 (5), 1345–1348 (2008).

4. D.R. Abernethy et al., "Adulteration of Drugs and Foods: Compendial Approaches to Lowering Risk," Clin. Pharm. Ther., in press (2008).

5. EMEA, Guideline on the Specification Limits for Residues of Metal Catalysts (London, March 2008), available at http://www.emea.europa.eu/, accessed Oct. 6, 2008.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here